id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-E-0381-0008,FDA,FDA-2021-E-0381,Notice of Final Determination,Other,Letter(s),2024-03-18T04:00:00Z,2024,3,2024-03-18T04:00:00Z,,2024-03-18T16:13:35Z,,0,0,090000648647caf6
FDA-2021-E-0381-0007,FDA,FDA-2021-E-0381,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2024-02-02T05:00:00Z,2024,2,2024-02-02T05:00:00Z,,2024-02-02T20:17:36Z,,0,0,09000064863da611